Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-0.10
%2.11
Latest4.84
High4.99
Low4.70
Volume181,594
Turnover (SEK)880,549
Market Cap (MSEK)259

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:06 PMNONAVA4.842,297
4:44 PMNONAVA4.847,774
4:44 PMNONAVA4.842,226
4:26 PMINTNON4.8782
4:23 PMNONAVA4.84280
3:55 PMAVANRD4.91346
3:07 PMAVANON4.8925
3:06 PMAVANRD4.911,700
2:51 PMSWBNON4.902,000
2:46 PMAVANON4.90100

Scheduled Reports

DateReport
2017-05-18Delårsrapport tre




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se